Background: Postoperative delirium continues to pose major clinical difficulties. While unmodifiable factors (e.g. age and comorbidity burden) are commonly studied risk factors for delirium, the role of modifiable factors, such as anaesthesia type and commonly used perioperative medications, remains understudied. This study aims to evaluate the role of modifiable factors for delirium after hip and knee arthroplasties. Methods: We performed a retrospective study of 41 766 patients who underwent hip or knee arthroplasties between 2005 and 2014 at a single institution. Data were collected as part of routine patient care. Multivariable logistic regression models assessed associations between anaesthesia type and commonly used perioperative medications (opioids, benzodiazepines, and ketamine) and postoperative delirium. Odds ratios (OR) and 95% confidence intervals (CI) are reported. Various sensitivity analyses are also considered, including multiple imputation methods to address missing data. Results: Postoperative delirium occurred in 2.21% (n¼922) of all patients. While patients who received neuraxial anaesthesia were at lower risk for postoperative delirium (compared with general anaesthesia; epidural OR 0.59 CI 0.38e0.93; spinal OR 0.55 CI 0.37e0.83; combined spinal/epidural OR 0.56 CI 0.40e0.80), those given intraoperative ketamine (OR 1.27 CI 1.01e1.59), opioids (OR 1.25 CI 1.09e1.44), postoperative benzodiazepines (OR 2.47 CI 2.04e2.97), and ketamine infusion (OR 10.59 CI 5.26e19.91) were at a higher risk. Conclusions: In this cohort of hip and knee arthroplasty patients, anaesthesia type and perioperative medications were associated with increased odds for postoperative delirium. Our results support the notion that modifiable risk factors may exacerbate or attenuate risk for postoperative delirium.
Postoperative delirium remains a major problem for perioperative clinicians and their patients, especially given its association with significant short-and long-term adverse outcomes.
1e3 While there is a general consensus regarding the role of unmodifiable risk factors for delirium, including older age and higher comorbidity burden (especially psychiatric), the role of modifiable risk factors, such as type of anaesthesia and perioperatively administered medications, is still disputed.
4e7
In a number of population-based studies, neuraxial anaesthesia has been associated with reduced perioperative complications when compared with general anaesthesia. 8e12 The question of whether this type of regional anaesthetic technique compared with a general anaesthetic approach can influence risk for delirium remains largely understudied. 6, 7 Further, the impact of commonly used perioperative medications on this outcome remains debated. 13 In the present study, we evaluated whether these factors may be associated with postoperative delirium among total hip and knee arthroplasty patients while controlling for a range of covariates. We hypothesised that postoperative delirium would occur at a higher rate among patients who received general anaesthesia, compared with those who underwent their procedures under neuraxial anaesthetics. We also considered the hypothesis that the use of medications perioperatively, namely opioids, ketamine, and benzodiazepines, would increase risk for delirium.
Methods
We conducted a retrospective study of patients who underwent elective total hip arthroplasties (THA) or total knee arthroplasties (TKA) at Hospital for Special Surgery between 2005 and 2014. This study was approved by the hospital institutional review board and was exempt from the requirement to obtain informed consent from patients, given the retrospective and observational nature of this analysis (IRB # 2016-436) . All data utilised for this study were collected as part of routine patient care.
Data sources
Patient characteristics and medical history were obtained from hospital billing datasets, which contained information such as age, sex, dates of admission and discharge, and International Classification of Diseases, 9
th Revision (ICD-9)
codes. The ICD-9 codes provided information about each patient's presenting diagnoses (i.e. their reason for surgery), their medical history, and any complications that developed during admission. ICD-9 procedure codes referring to THA (81.51) and TKA (81.54) were used to identify patients for the period 2005e2014. Patients who appeared more than once in the database (i.e. those who had more than one THA, TKA, or both) were included only for the first procedure. Thus, no patient was counted more than once in the analysis. Exclusion criteria are outlined in Fig. 1 . After applying these criteria, the study cohort consisted of 41 766 unique patients (21 022 THA and 20 744 TKA).
Study variables
For ICD-9 diagnosis codes, a present on admission (POA) indicator was used to distinguish diagnoses referring to prior conditions from those that emerged during their hospital stay. Postoperative delirium was defined using the following non-POA ICD-9 diagnosis codes: 292.81, 293.0, 293.1, 293.9, 780.09, and 780.97. These diagnosis codes were selected based on codes described in previous publications, which we considered relevant to the current study population. Initially, the following additional ICD-9 codes were included in our definition for postoperative delirium, but were found to have a frequency of zero in the current study cohort: 293.8, 293.81, 293.82, 293.83, 293.84, 293.89, and 797. Although our dataset lacked information regarding the timing of the delirium diagnosis, we could assume that the diagnosis took place after operation. Due to the elective nature of the THA and TKA procedures considered in this study, as per hospital practice, the surgery would have been cancelled had the symptoms of delirium emerged before operation.
ICD-9 diagnosis codes marked either with a POA indicator of 'Y' (Yes) or that were classified as exempt from POA reporting were used for assessing each patient's comorbidity burden. Each patient's comorbidity status was evaluated for each of the following diagnoses: hypothyroidism; renal disease; diabetes; obesity; sleep apnoea; valvular disease; hypertension; congestive heart failure; tobacco abuse; pulmonary disease; depression/anxiety; and psychoses.
A hospital anaesthesia billing database was used to identify the primary type of anaesthesia for each patient as one of the following: general; combined spinal epidural (CSE); epidural; or spinal. Patients whose anaesthesia type was missing were excluded.
Use of intraoperative medications commonly suggested to potentially affect the risk of delirium, such as benzodiazepines, ketamine, and opioids, were identified from institutional pharmacy datasets stored in the Omnicell database (Omnicell Inc., Mountain View, CA, USA). Medications administered on the date of surgery that were obtained from pharmacy storage devices accessible to the anaesthesiologist from the operating room were assumed to have been given intraoperatively. For each patient, a binary indicator variable was used to identify whether or not the patient received that medication intraoperatively (e.g. 1 ¼ medication given, 0 ¼ medication not given).
Postoperative (i.e. on Days 0, 1, and 2) benzodiazepines and ketamine infusions were also defined as binary indicator variables. Postoperative opioid use was not considered in our analysis, because the vast majority of patients receive opioids for postoperative pain management.
Postoperative medications administered in the hospital ward were stored in CliniCIS, a computerised physician order entry system managed by Allscripts Healthcare Solutions Inc. (Chicago, IL, USA). These data were available only for patients whose procedures took place in 2007 or later.
We also defined the specific doses (in mg) of these perioperative medications for the purpose of a sensitivity analysis. Doses of intraoperative opioids were computed for each patient as the total oral morphine equivalent dose, based on conversion ratios provided by the Global RPh calculator. 17 Intraoperative and postoperative benzodiazepine quantities were converted to equivalent i.v. midazolam doses using conversion ratios described in various sources.
18e21 To compute the total intraoperative ketamine dose, it was not necessary to use any conversion ratios. Postoperative ketamine was administered as an infusion and analysed only as a dichotomous variable. This decision was based on the small proportion of patients receiving ketamine infusions (i.e. approximately 0.3%) and rather large doses (i.e. averaging >1500 mg) administered.
Based on the information provided in the Omnicell database, a specific dose of each intraoperative medication administered to each patient could be calculated using the following formula: [quantity in mg removed from pharmacy storage device] e [quantity returned to pharmacy device] e [quantity 'wasted' (i.e. neither given to patient nor returned to device)]. Postoperative medication data from CliniCIS did not require this formula because the doses recorded in the data reflected the quantity that was actually given to the patient.
Baseline laboratory values were obtained from two institutional databases utilised over the course of the study time frame. Before 2007, laboratory data were kept in a database managed by Psyche Laboratory Software (Milford, MA, USA). Subsequent years of laboratory data were stored in CliniCIS. Baseline values of sodium, creatinine, and haemoglobin were classified as those measured before the date of admission for surgery.
Statistical analysis
First, a descriptive summary of patient characteristics, stratified by postoperative delirium status was conducted. Categorical variables were analysed using a c 2 test and are reported as frequency (%). Continuous variables are reported as median (interquartile range) and were compared across the delirium groups using two-sample t-tests. Categorical and continuous variables were also stratified by anaesthesia type and analysed in a similar manner. (The only exception was that a one-way analysis of variance test was used for analysing continuous variables across the four anaesthesia categories).
Odds ratios (OR) and 95% confidence intervals (CI) for postoperative delirium were determined using multivariable logistic regression, adjusted for the following covariates: type of surgery (TKA or THA); age at surgery (in years); time period in which the surgery occurred (categorised by 2005e2006, 2007e2008, 2009e2010, 2011e2012, or 2013e2014); sex (male or female); baseline laboratory values (haemoglobin, sodium, and creatinine); primary type of anaesthesia (general, CSE, epidural or spinal); dichotomised intraoperative medications (opioids, benzodiazepines, and ketamine); dichotomised postoperative medications (benzodiazepines and ketamine); and comorbidities.
For each logistic regression model, an area under the receiver operating curve (AUC) was determined to assess the model's ability to distinguish between patients by postoperative delirium status. The initial regression model included only those patients who were not missing any data for any of the covariates of interest. In particular, 27 607 patients (66.1%) had complete data (13 807 THA and 13 800 TKA) and were included in the initial statistical analysis.
Subsequently, a sensitivity analysis involved incorporating all 41 766 patients, including those with missing data, after applying multiple imputation techniques to approximate missing values of the baseline laboratory values and intraoperative and postoperative medications. Imputation procedures were implemented under the assumption that data were missing at random. 22, 23 Missing values for dichotomous variables (e.g. opioids, benzodiazepines, and ketamine) were imputed using logistic regression imputation. Missing continuous data (e.g. haemoglobin, sodium, creatinine, and the continuous medication dose variables used in the final sensitivity analysis) were imputed using predictive mean matching. After incorporating the imputed data in a logistic regression model, the resulting adjusted odds ratios were compared between the initial analysis and the postimputation logistic regression model. Two sensitivity models were analysed using the complete (i.e. imputed) dataset to consider the possibility that including both intraoperative and postoperative benzodiazepines and ketamine in the models may have resulted in multicollinearity. Each model included the same covariates as in the initial analysis, except one removed the postoperative medications, and the other removed the intraoperative medications. Intraoperative opioids were included in both sensitivity models given that we did not consider postoperative opioid use for the previously stated reason.
A final sensitivity analysis considered possible dosespecific effects of the perioperative medications on risk for postoperative delirium by replacing the dichotomised intraoperative and postoperative medication variables with continuous ones, specifying the total doses that each patient received during and after operation. Intraoperative opioid and ketamine doses were quantified on a scale per 10 mg given, while benzodiazepines were quantified per 1 mg given.
All analyses were performed using R version 3.3.3 and RStudio version 1.0.136 as an interface. 24, 25 The package 'tableone' was used for presenting statistical summaries, 26 the package 'pROC' was used for determining AUCs, 27 and the package 'mice' was used for implementing multiple imputation. 23 
Results
Of the 41 766 patients in the cohort, 922 (2.21%) had at least one ICD-9 code indicating postoperative delirium. Postoperative delirium was more prevalent among TKA patients (2.76%) than among THA patients (1.66%). Patients with postoperative delirium had significantly longer hospital stay, older age, higher baseline creatinine, lower haemoglobin, and higher overall comorbidity burden compared with those who did not develop delirium (Table 1 ). There were also significant differences by delirium status for time period, intraoperative benzodiazepine use, and postoperative benzodiazepine and ketamine use. Supplementary Appendix S1 provides an overview of all study variables by type of anaesthesia. Interestingly, patients with general anaesthesia (compared with neuraxial anaesthesia) received more ketamine and opioids, thus justifying the addition of these variables in a multivariable model when assessing the role of anaesthesia type in risk for developing postoperative delirium.
The first multivariable logistic regression model included only those patients with no missing data (n¼27 607). Of those, 567 (2.05%) developed postoperative delirium. Adjusting for covariates, TKA patients had higher odds of delirium compared with THA patients, and patients who received CSE or spinal anaesthesia had significantly lower odds of delirium compared with those who were given general anaesthesia (Table 2) . Those who received epidural anaesthesia had a trend towards reduced risk for postoperative delirium, compared with general anaesthesia patients, but this difference did not reach statistical significance. Both intraoperative and postoperative medication use were associated with increased odds of delirium, except for intraoperative benzodiazepines. While postoperative benzodiazepines were associated with significantly increased odds of delirium, intraoperative benzodiazepines had the opposite effect. Patients with pre-existing psychiatric comorbidities and those with diabetes were also at greater risk for developing postoperative delirium. As a result of missing postoperative medication data for all patients in the 2005e2006 time period category, only four time periods were considered in this model. An AUC of 0.8405 implies that the model effectively discriminated between patients by delirium status.
To evaluate the potential influence of missing data, we conducted the same logistic regression analysis utilising a dataset of all 41 766 patients in this cohort, with imputed values in the place of data points missing from the original data (Table 3) . The results support mostly consistent findings regarding our hypotheses as in Table 2 Using the imputed dataset, two additional models were considered as part of a sensitivity analysis (Table 4) . Adjusting for the same covariates, but removing postoperative benzodiazepines and ketamine from the first model, and removing intraoperative benzodiazepines and ketamine from the second model, we again observed similar trends in the factors impacting the odds of postoperative delirium.
In a final sensitivity analysis, we considered the possible impact of the dichotomising perioperative medication variables, and incorporated the doses of these medications (except for postoperative ketamine infusions) in a model. The results, which are presented in Supplementary Appendix S2, support the previous findings that intraoperative opioids and postoperative benzodiazepines are associated with significantly increased risk for delirium, with a comparable AUC of 0.8335. The effects of intraoperative benzodiazepines and ketamine approached statistical significance with P<0.1.
Discussion
In this cohort of 41 766 TKA and THA patients, both unmodifiable and modifiable factors contributed to risk for postoperative delirium. Consistent with previous literature, we found that older age and higher comorbidity (especially psychiatric) burden were associated with this increased risk. As we hypothesised, patients who received neuraxial anaesthesia had significantly lower odds of developing postoperative delirium compared with those who received general anaesthesia. Importantly, this finding expands on the implications of existing research favouring neuraxial over general anaesthesia in terms of reduced postoperative complications in general, and it adds to the limited amount of research that has been done thus far on modifiable risk factors for postoperative delirium. 4e12 Additionally, as hypothesised, patients who were given intraoperative opioids and ketamine and postoperative ketamine and benzodiazepines were at significantly greater risk for delirium compared with those who were not given these medications at these perioperative time points. In contrast to our hypothesis and to previous literature, intraoperative benzodiazepines were associated with reduced odds for delirium. We found general anaesthesia to be associated with increased odds for the outcome of postoperative delirium. It has been speculated that the interaction of general anaesthetics and brain function may be responsible for alterations of brain function, potentially including delirium. 28 16 studies included in the review to suggest differences in postoperative function associated with anaesthetic type. In contrast, in studies of delirium in populations where regional anaesthesia is predominantly useddincluding in the present studydrates of delirium have been remarkably low. 30 In addition to general anaesthesia, our primary analyses suggested that perioperatively administered opioids, ketamine, and benzodiazepines (except intraoperative benzodiazepines) increased risk for delirium among patients in this cohort. However, in our final sensitivity model, intraoperative benzodiazepines and ketamine were no longer found to be associated with modified risk for postoperative delirium. It is also notable that the AUC of the sensitivity model did not show improvements from that of the original model, suggesting that including the specific doses of these medications did not result in improved ability of the model to predict a patient's delirium status. Importantly, the discrepancy in the results when medications were treated as dichotomous vs continuous variables suggests a possible threshold dose for intraoperative benzodiazepines and ketamine, such that risk for delirium may only be altered when dose exceeds that threshold. Future studies should seek to identify such a threshold.
In both the primary analyses and sensitivity models, intraoperative opioid use was linked to significantly higher odds of delirium. Perioperative opioids have been linked to sleep disturbances, which may negatively impact cognitive function. 31 In one review of opioid usage among chronic pain patients, the cognitive side effects from opioids were most apparent within several hours of an initial dose, 32 which could explain the increased risk for postoperative delirium among patients who received opioids intraoperatively.
Avidan and colleagues' recent multicentre randomised control trial of postoperative outcomes after major surgery in elderly patients suggests an association between higher doses of ketamine and more frequent episodes of altered cognitive status such as hallucinations and nightmares. 13 Although this study did not find significant differences in diagnosis of delirium per se between the ketamine and placebo groups, the results support the notion that ketamine may increase risk for adverse cognitive outcomes in general. 13 Our results did not confirm an association between intraoperative benzodiazepines and postoperative delirium as previously suggested. 33, 34 We speculated that this may have been the result of confounding by indication bias. In particular, anaesthesiologists may have been disinclined to prescribe benzodiazepines to patients already at greater risk for perioperative complications, including delirium (i.e. patients who are older or have higher comorbidity burden). To evaluate this hypothesis, we conducted a post hoc analysis (using the imputed dataset), removing age and comorbidities as covariates in the logistic regression model. We found that the adjusted OR of delirium for patients who were given benzodiazepines intraoperatively reduced by >60%. Thus, correlation between these covariates may explain the divergence of our results from our hypothesis and from findings in previous literature. Several other limitations of this study should also be addressed. In regard to medication use, we did not have access to information specifying the reason for their administration. In some hospital settings, a postoperative prescription of benzodiazepines, ketamine, or both may indicate treatment for delirium, therefore suggesting that the delirium diagnosis may have preceded the administration of these medications, rather than the medications being a risk factor that preceded the onset of delirium. However, at the hospital where this study was conducted, it is not common practice to administer benzodiazepines or ketamine to treat delirium; rather, various other agents would typically be used.
It has also been suggested that postoperative pain may be an important predictor of postoperative delirium. 35 Thus, another limitation of the study is that we did not have access to pain scores. In this context, theoretically, the use of opioids and ketamine may indicate increased pain levels as a potential driver of the increased delirium risk; however, univariably (Table 1) , there were no differences in opioid and ketamine use between groups. The study cohort was limited to TKA and THA patients, who may be subject to unique perioperative insults and pathophysiological mechanisms. 36 Additionally, data are derived from a single institution, which may not allow for generalisability to a broader surgical population. Future studies should consider incorporating multicentre data to study a more representative cohort. This study was conducted over a 10-year period during which several different institutional databases were used to collect patient data. Inconsistencies in data collection methods across these databases resulted in missing data because of difficulties merging patient data across these databases. Data were also missing for time periods during which certain pieces of data were missing entirely (e.g. postoperative medication data missing before 2007), and other individual instances of missing data for unknown reasons. Another limitation is that we were only able to adjust for measured confounders. Thus, it may be beneficial for future studies to account for additional confounding variables that were not accessible in the administrative data sources used for this study. With the recent integration of more cohesive electronic health record database systems at many hospitals, there is great opportunity for conducting large observational studies with reduced missing data and a wider range of clinical variables, which may reduce biased estimates.
Further, the use of ICD-9 codes may have resulted in underestimation of the prevalence of postoperative delirium in this cohort. 14, 37 It is also plausible that diagnoses of hyperactive delirium would have been disproportionately represented in this study, compared with the hypoactive type. While it has been suggested by some authors that hypoactive is more common than hyperactive delirium, 38e40 a recent retrospective study found notably lower incidence of hypoactive delirium because of possible lack of routine screening for symptoms of hypoactive delirium. In contrast, hyperactive delirium would be more easily recognised. 41 This study also had several strengths that are worth noting. Given that data from a high-volume orthopaedics hospital were utilised for the study, there was a sufficiently large sample size in each group (delirium vs no delirium), despite the relatively low incidence of this event. Although we did not perform an a priori sample size calculation because of the retrospective nature of the study, a post hoc power analysis revealed that our data had above 91% power to detect the observed differences in postoperative delirium rates between patients who received neuraxial vs general anaesthesia at a significance level of 0.01 and >97% power to detect this difference at a significance level of 0.05. The substantial sample size of the study allowed for minimal bias in our logistic regression estimates, as we were able to adhere to the common recommendation to include a maximum of one covariate per 10 cases of the outcome of interest. 42 In summary, we found an association between perioperative modifiable risk factorsdgeneral anaesthesia, opioids, ketamine, and postoperative benzodiazepinesdand postoperative delirium. Unmodifiable factors, such as age and comorbidity burden, clearly pose a significant risk for postoperative delirium, and our results support the notion that such risk may be attenuated through modification of intraoperative anaesthetics and prescription of medications.
While further research will be necessary to establish the generalisability of these findings and to investigate specific medication dose thresholds and other factors impacting risk for delirium, 43e45 the current study provides a basis in support of the role of perioperative modifiable risk factors for postoperative delirium.
